PRTA Projected Dividend Yield
Ord/Prothena Corp Plc ( NASDAQ : PRTA )Prothena Corporation plc is an Ireland-based late-stage clinical biotechnology company. Co. is engaged in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid diseases. Co. is advancing a pipeline of therapeutic candidates for a range of indications and targets to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins. Co.'s pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases, including AL amyloidosis, ATTR amyloidosis, Alzheimer's disease, Parkinson's disease and a range of other neurodegenerative diseases. 21 YEAR PERFORMANCE RESULTS |
PRTA Dividend History Detail PRTA Dividend News PRTA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |